Maralixibat
Back to searchMolecule Structure
Scientific Name
Maralixibat
Description of the Drug
Maralixibat is an ileal bile acid transporter inhibitor indicated to treat cholestatic pruritus in patients with Alagille syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB16226
http://www.drugbank.ca/drugs/DB16226
Brand Name(s)
Not Available
Company Owner(s)
Mirum Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Ileal bile acid transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL2778 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL10013954 |
| PharmGKB | PA166268803 |
| DrugBank | DB16226 |
| PubChem | 9831643 |
| BindingDB | 50140282 |
